Form 8-K - Current report:
SEC Accession No. 0000886163-19-000088
Filing Date
2019-05-24
Accepted
2019-05-24 16:28:06
Documents
1
Period of Report
2019-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-form8xk_52419.htm 8-K 26239
  Complete submission text file 0000886163-19-000088.txt   27366
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 19854820
SIC: 2834 Pharmaceutical Preparations